drugset / Trial / NCT00887809
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test whether an experimental drug called bevacizumab given together with gemcitabine and docetaxel, a standard chemotherapy regimen for sarcoma, can help sarcoma patients. This trial will examine what effects, good and/or bad the combination of gemcitabine, docetaxel and bevacizumab has on sarcoma.
Timeline
- Start
- 2009-04
- Primary completion
- 2014-10
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | Intravenous |
| Background | Docetaxel | Small molecule | 35 mg/m2 | — |
| Background | Gemcitabine | Small molecule | 800 mg/m2 | — |